clinicla chemistry reagent manufacturer. iso certified. a division of escalon medical corp.
Company profile
Ticker
ESMC
Exchange
Website
CEO
Richard J. DePiano
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Integer • Masimo • Natus Medical • LivaNova • BioPlus Acquisition • QT Imaging • Outset Medical ...
SEC CIK
Corporate docs
IRS number
330272839
ESMC stock data
Latest filings (excl ownership)
10-Q
2024 Q2
Quarterly report
14 Feb 24
10-Q
2024 Q1
Quarterly report
17 Nov 23
NT 10-Q
Notice of late quarterly filing
15 Nov 23
10-K
2023 FY
Annual report
13 Oct 23
NT 10-K
Notice of late annual filing
29 Sep 23
10-Q
2023 Q3
Quarterly report
15 May 23
10-Q
2023 Q2
Quarterly report
14 Feb 23
10-Q
2023 Q1
Quarterly report
14 Nov 22
8-K
Changes in Registrant's Certifying Accountant
2 Nov 22
10-K
2022 FY
Annual report
28 Sep 22
Latest ownership filings
SC 13D
Escalon Medical Corp
23 Oct 18
3
John Dogum
22 Feb 18
3
David James Jacovini
21 Feb 18
4
RICHARD J DEPIANO
16 Feb 18
SC 13G/A
Escalon Medical Corp
13 Feb 18
SC 13G/A
Escalon Medical Corp
10 Feb 17
SC 13G/A
Escalon Medical Corp
30 Nov 16
4
C Sean Closkey
16 May 16
4
RICHARD J DEPIANO
16 May 16
4
C Todd Trusk
16 May 16
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jun 23 | Jun 22 | Jun 21 | Jun 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.00 mm | 1.00 mm | 1.00 mm | 1.00 mm | 1.00 mm | 1.00 mm |
Cash burn (monthly) | 48.27 k | (no burn) | 5.22 k | (no burn) | 38.65 k | (no burn) |
Cash used (since last report) | 320.56 k | n/a | 34.64 k | n/a | 256.70 k | n/a |
Cash remaining | 680.60 k | n/a | 966.52 k | n/a | 744.46 k | n/a |
Runway (months of cash) | 14.1 | n/a | 185.3 | n/a | 19.3 | n/a |
Institutional ownership, Q4 2019
0.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 1.31 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Victory Capital Management | 1.31 k | $0.00 |